{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:14:30Z","timestamp":1782278070615,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T00:00:00Z","timestamp":1666396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T00:00:00Z","timestamp":1666396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"crossref","award":["CRG\/2018\/003176"],"award-info":[{"award-number":["CRG\/2018\/003176"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"crossref","award":["CRG\/2018\/003176"],"award-info":[{"award-number":["CRG\/2018\/003176"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00210-022-02309-0","type":"journal-article","created":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T11:40:02Z","timestamp":1666438802000},"page":"239-246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A comparison of dissolving microneedles and transdermal film with solid microneedles for iloperidone in vivo: a proof of concept"],"prefix":"10.1007","volume":"396","author":[{"given":"Rupali S.","family":"Bhadale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali Y.","family":"Londhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,22]]},"reference":[{"key":"2309_CR1","unstructured":"Accessdata.fda.gov. (2022). Retrieved 23 March 2022, from https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215413s000lbl.pdf"},{"key":"2309_CR2","doi-asserted-by":"publisher","unstructured":"Bhadale R, Londhe V (2021) A systematic review of carbohydrate-based microneedles: current status and future prospects. J Mater Sci Mater Med 32(8). https:\/\/doi.org\/10.1007\/s10856-021-06559-x","DOI":"10.1007\/s10856-021-06559-x"},{"key":"2309_CR3","doi-asserted-by":"publisher","first-page":"103063","DOI":"10.1016\/j.jddst.2021.103063","volume":"68","author":"R Bhadale","year":"2022","unstructured":"Bhadale R, Londhe V (2022) Inclusion complexed iloperidone loaded dissolving microneedles: characterization, in-vitro study, and dermatopharmacokinetics. J Drug Deliv Sci Technol 68:103063. https:\/\/doi.org\/10.1016\/j.jddst.2021.103063","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"2309_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.psychres.2013.08.035","volume":"210","author":"M Bo\u0161kovi\u0107","year":"2013","unstructured":"Bo\u0161kovi\u0107 M, Grabnar I, Terzi\u010d T, Kores Plesni\u010dar B, Vovk T (2013) Oxidative stress in schizophrenia patients treated with long-acting haloperidol decanoate. Psychiatry Res 210(3):761\u2013768. https:\/\/doi.org\/10.1016\/j.psychres.2013.08.035","journal-title":"Psychiatry Res"},{"key":"2309_CR5","doi-asserted-by":"publisher","unstructured":"Citrome L, Zeni C, Correll C (2019) Patches. J Clin Psychiatry 80(4). https:\/\/doi.org\/10.4088\/jcp.18nr12554","DOI":"10.4088\/jcp.18nr12554"},{"key":"2309_CR6","unstructured":"Dosage & application | SECUADO\u00ae (asenapine) Patch. Secuado. (2022). Retrieved 23 April 2022, from https:\/\/www.secuado.com\/hcp\/prescribing-secuado\/"},{"key":"2309_CR7","doi-asserted-by":"publisher","unstructured":"Ellenbroek B, Peeters B, Honig W, Cools A (1987) The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugs. Psychopharmacology 93(3). https:\/\/doi.org\/10.1007\/bf00187254","DOI":"10.1007\/bf00187254"},{"key":"2309_CR8","unstructured":"Ema.europa.eu. (2022). Retrieved 15 January 2022, from https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/fanaptum-epar-refusal-public-assessment-report_en.pdf.HighlightsofPrescribingMedication. www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/022192s007lbl.pdf"},{"issue":"4","key":"2309_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3390\/pharmaceutics7040379","volume":"7","author":"M Hoang","year":"2015","unstructured":"Hoang M, Ita K, Bair D (2015) Solid microneedles for transdermal delivery of amantadine hydrochloride and pramipexole dihydrochloride. Pharmaceutics 7(4):379\u2013396. https:\/\/doi.org\/10.3390\/pharmaceutics7040379","journal-title":"Pharmaceutics"},{"key":"2309_CR10","doi-asserted-by":"publisher","first-page":"110409","DOI":"10.1016\/j.colsurfb.2019.110409","volume":"183","author":"V Londhe","year":"2019","unstructured":"Londhe V, Bhasin B (2019) Transdermal lipid vesicular delivery of iloperidone: formulation, in vitro and in vivo evaluation. Colloids Surf B Biointerfaces 183:110409. https:\/\/doi.org\/10.1016\/j.colsurfb.2019.110409","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"3","key":"2309_CR11","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1208\/s12249-018-0954-y","volume":"19","author":"V Londhe","year":"2018","unstructured":"Londhe V, Shirsat R (2018) Formulation and characterization of fast-dissolving sublingual film of iloperidone using Box-Behnken design for enhancement of oral bioavailability. AAPS PharmSciTech 19(3):1392\u20131400. https:\/\/doi.org\/10.1208\/s12249-018-0954-y","journal-title":"AAPS PharmSciTech"},{"key":"2309_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.molstruc.2017.12.042","volume":"1157","author":"V Londhe","year":"2018","unstructured":"Londhe V, Deshmane A, Singh S, Kulkarni Y (2018) Lurasidone-\u03b2-cyclodextrin complexes: physicochemical characterization and comparison of their antidepressant, antipsychotic activities against that of self microemulsifying formulation. J Mol Struct 1157:395\u2013400. https:\/\/doi.org\/10.1016\/j.molstruc.2017.12.042","journal-title":"J Mol Struct"},{"key":"2309_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jconrel.2014.02.007","volume":"180","author":"M McCrudden","year":"2014","unstructured":"McCrudden M, Alkilani A, McCrudden C, McAlister E, McCarthy H, Woolfson A, Donnelly R (2014) Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs. J Control Release 180:71\u201380. https:\/\/doi.org\/10.1016\/j.jconrel.2014.02.007","journal-title":"J Control Release"},{"key":"2309_CR14","unstructured":"Mental disorders. Who.int. (2022). Retrieved 23 January 2022, from https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/mental-disorders"},{"issue":"1","key":"2309_CR15","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1080\/10717544.2017.1337826","volume":"24","author":"A Omolu","year":"2017","unstructured":"Omolu A, Bailly M, Day R (2017) Assessment of solid microneedle rollers to enhance transmembrane delivery of doxycycline and inhibition of MMP activity. Drug Delivery 24(1):942\u2013951. https:\/\/doi.org\/10.1080\/10717544.2017.1337826","journal-title":"Drug Delivery"},{"issue":"5","key":"2309_CR16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jpsychires.2006.01.011","volume":"41","author":"A Pillai","year":"2007","unstructured":"Pillai A, Parikh V, Terry A, Mahadik S (2007) Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J Psychiatr Res 41(5):372\u2013386. https:\/\/doi.org\/10.1016\/j.jpsychires.2006.01.011","journal-title":"J Psychiatr Res"},{"key":"2309_CR17","unstructured":"Schizophrenia facts and statistics. Schizophrenia.com. (2022). Retrieved 23 January 2022, from http:\/\/schizophrenia.com\/szfacts.htm"},{"issue":"3","key":"2309_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/10673220600748486","volume":"14","author":"A Shirzadi","year":"2006","unstructured":"Shirzadi A, Ghaemi N (2006) Side effects of atypical antipsychotics: extrapyramidal symptoms and the metabolic syndrome. Harv Rev Psychiatry 14(3):152\u2013164. https:\/\/doi.org\/10.1080\/10673220600748486","journal-title":"Harv Rev Psychiatry"},{"issue":"3","key":"2309_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/0019-5545.43627","volume":"50","author":"O Singh","year":"2008","unstructured":"Singh O, Chakraborty I, Dasgupta A, Datta S (2008) A comparative study of oxidative stress and interrelationship of important antioxidants in haloperidol and olanzapine treated patients suffering from schizophrenia. Indian J Psychiatry 50(3):171. https:\/\/doi.org\/10.4103\/0019-5545.43627","journal-title":"Indian J Psychiatry"},{"key":"2309_CR20","unstructured":"Test No. 404: acute dermal irritation\/corrosion | en | OECD. Oecd.org. (2022). Retrieved 23 May 2022, from https:\/\/www.oecd.org\/env\/test-no-404-acute-dermal-irritation-corrosion-9789264242678-en.htm"},{"issue":"9690","key":"2309_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/s0140-6736(09)60995-8","volume":"374","author":"J Van Os","year":"2009","unstructured":"Van Os J, Kapur S (2009) Schizophrenia. The Lancet 374(9690):635\u2013645. https:\/\/doi.org\/10.1016\/s0140-6736(09)60995-8","journal-title":"The Lancet"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02309-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-022-02309-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02309-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T10:07:13Z","timestamp":1673345233000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-022-02309-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,22]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["2309"],"URL":"https:\/\/doi.org\/10.1007\/s00210-022-02309-0","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,22]]},"assertion":[{"value":"7 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal samples were obtained and ethical committee approval (Protocol number: CPCSEA\/IAEC\/P-19\/2019). All authors have reviewed and agreed with the content of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed, agreed with the content of the manuscript, and consented to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}